Search

Issue
Title
Authors
Clinical and morphological features of breast tumors with PIK3CA mutations in Russian patients: Observational study
Sokolova T.N., Solov'eva T.I., Aleksakhina S.N., Janus G.A., Goryainova A., Gluzman M.I., Orlova R.V., Stukan A.I., Zukov R.A., Zyuzyukina A.V., Murunova Y.N., Sultanbaev A.V., Vorobeva E.N., Mikhaevich L.M., Pyliv V.N., Lysenko A.N., Khachmamuk Z.K., Kozlov A.E., Bakharev S.Y., Parsyan S.G., Rossokha E.I., Osidze L.D., Shumskaya I.S., Agaeva A.V., Kasmynina T.A., Klimenko V.V., Akhmetgareeva K.T., Vakhitova A.A., Chakhkieva M.D., Dmitriev V.N., Bakshun Y.I., Vasilyev A.E., Gasimly D.D., Kravchenko N.A., Maksimov D.A., Nesterova A.I., Sharvashidze I.O., Gadzaova C.H., Rakhmankulova G.G., Khamgokov Z.M., Amirkhanova I.K., Bembeeva L.V., Vladimirov V.I., Petrenko O. ., Ruskova N.G., Serikova E.L., Subbotina K.S., Tkachenko S.A., Chang V.L., Erdniev S.P., Barbara V.S., Vasilevskaya A.V., Mikheeva Y.V., Popova N.O., Startseva E.P., Fateeva A.V., Yukalchuk D.Y., Grechkina A.A., Musaeva K.S., Odintsova S.V., Stel'makh A.S., Khabibulaeva P.I., Khlobystina A.G., Shvaiko K.A., Basova E.A., Bogomolova I.A., Bolieva M.B., Goldberg V.E., Kibisheva M.V., Menshikov K.V., Ryazanov D.V., Stepanova M.L., Udalova Y.A., Shkradyuk A.V., Chapko Y.S., Shchukina A.A., Khabriev I.M., Kirtbaya D.V., Degtyarev A.M., Epkhiev A.A., Tyugina Y.A., Murachuev M.A., Togo A.V., Ievleva A.G., Imyanitov E.N.
PARP (Poly ADP‐Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer (Russian Translation of Cochrane Plain Language Summary)
Uvarova K.G.
The era of immuno-oncology in onco-urology: what have we achieved? The review of the symposium of the alliance between Merck and Pfizer held within the framework of the XXV Russian Oncology Congress. November 9, 2021
Editorial B.
Avastin in clinical chemotherapy of malignant tumors
Gorbunova V.A.
Surgical treatment of recurrent ovarian cancer: A review
Egenov O.A., Stilidi I.S., Tyulyandina A.S.
HPV-associated lesions in the Russian Federation: assessment of the problem
Briko N.I., Lopukhov P.D., Kaprin A.D., Novikova E.G., Trushina O.I., Khaldin A.A., Isaeva D.R., Skvortsova A.I.
Management of patients with hormone receptor-positive HER2-negative metastatic breast cancer: data of randomized trials and real-world evidence
Editorial B.
Gastric cancer: Russian clinical guidelines
Besova N.S., Kalinin A.E., Nered S.N., Triakin A.A., Gamaiunov S.V., Kozlov N.A., Stilidi I.S., Karachun A.M., Kononets P.V., Malikhova O.A., Riabov A.B., Khomiakov V.M., Fedenko A.A., Bolotina L.V., Falaleeva N.A., Nevol'skikh A.A., Ivanov S.A., Khailova Z.V., Gevorkian T.G., Butenko A.V., Gil'mutdinova I.R., Eremushkin M.A., Ivanova G.E., Kondrat'eva K.O., Konchugova T.V., Krutov A.A., Obukhova O.A., Semiglazova T.I., Filonenko E.V., Khulamkhanova M.M., Romanov A.I.
The consensus on the prevention and correction of rash in patients with HR+ HER2- metastatic breast cancer treated with alpelisib
Shlivko I.L., Garanina O.E., Artamonova E.V., Ganshina I.P., Zhukova L.G., Koroleva I.A., Michenko A.V., Semiglazova T.Y., Filonenko D.A.
Multicenter prospective observational post-approval study of safety and efficacy of bevacizumab (Avegra®, BIOCAD) in patients with metastatic colorectal cancer in real world practice: APOLLON-11 and SOYUZ-APOLLON
Tryakin A.A., Fedyanin M.Y., Moiseenko F.V., Mironov O.V., Stroyakovskiy D.L., Sokolov N.I., Orlova S.A., Mantsyrev E.O., Sultanbaev A.V., Teterich A.A., Babina K.G., Yukalchuk D.Y., Borzyanitsa S.M., Isyangulova A.Z., Saidullaeva A.F., Chernova Y.A., Bobrova E.A., Fadeeva N.V., Chobanu D.Y.
Atezolizumab in the first-line treatment of metastatic non-small cell lung cancer. Clinical experience of the drug application. Case report
Ognerubov N.A., Antipova T.S.
Osimertinib and routine practice: the experience of the drug application in different clinical situations in case of metastatic non-small cell lung cancer with an EGFR mutation. Case report
Orlov S.V., Baldin P.L., Diuzeva N.V., Krechetova A.V., Mordovskiy A.A., Moskovchenko A.N., Musaeva N.E., Romanchuk O.V.
Assessment of the impact of the use of durvalumab for the treatment of advanced small cell lung cancer on the achievement of the target "reduction in mortality from neoplasms"
Ryazhenov V.V., Orlov S.V., Ivakhnenko O.I.
Own Experience of Using Lenvatinib in Patients with Advanced Hepatocellular Carcinoma in Real Clinical Practice based on Moscow City Oncological Hospital №62
Volkonsky M.V., Zhikhorev R.S., Makarkina T.A., Filippova V.M., Vasileva Y.V., Akopyan A.A., Zhelezkova T.A.
Laparoscopic resections of the liver and the colon in patients with synchronous colorectal metastases: a case series
Lyadov V.K., Moskalenko A.N., Britskaia N.N.
Targeted therapy of brain metastases in patients with ALK-positive non-small cell lung cancer: A review
Sakaeva D.D., Bulavina I.S.
Comparative analysis results of surgical treatment, chemoradiotherapy and chemotherapy with assessment of prognostic factors in cervical esophageal cancer
Radzhabova Z.A., Kotov M.A., Girshovich M.M., Ponomareva O.I., Tkachenko E.V., Mitrofanov A.S., Radzhabova M.A., Levchenko E.V.
Endoscopic esophageal stenting in combination with chemoradiation therapy: A review
Ivanov A.I., Popov V.A., Burmistrov M.V.
Features of response to modern neoadjuvant chemotherapy with dual anti-HER2 blockade (trastuzumab and pertuzumab) in the patients with HER2-positive breast cancer stage II–III
Morozov D.A., Kolyadina I.V., Poddubnaya I.V., Ganshina I.P., Khokhlova S.V., Kоmetova V.V., Rodionov V.V.
The ability to combine autodermoplasty in the treatment of patients with malignant tumors of the skin extremities (clinical observation)
Vaschenko L.N., Dashkova I.R., Kechedzhieva E.E., Babieva S.M.
Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer (Russian Translation of Cochrane Plain Language Summary – PLS)
Alexandrova E.G.
Immuno-morphological characteristics of bone marrow in patients with ovarian cancer
Kozhonalieva A.M., Chulkova S.V., Stilidi I.S., Artamonova E.V., Poddubnaya I.V., Kolbatskaya O.P., Kupryshina N.A., Egorova A.V., Tupitsyn N.N.
Innovations in practice. 5 years of palbociclib experience in the Russian Federation. Overview of web-conference took place on 8 October 2021
Editorial B.
Keliks (pegilirovannyy liposomal'nyy doksorubitsin) v programmnoy terapii 2-y linii metastaticheskogo raka molochnoy zhelezy
Clinical prognostic factors of bilateral synchronous renal cancer
Komarov M.I., Matveev V.B., Volkova M.I., Komarov I.G., Ridin V.A.
Anxiety and cognitive impairment in elderly patients with gastrointestinal cancers
Stilidi I.S., Kotyukova A.Y., Lyadov V.K.
Passive smoking prevalence among patients of krasnoyarsk regional oncologic dispensary
Kutumova O.Y., Kononova L.I., Dobretsova E.A., Shulmin A.B., Korotkova K.M., Rossiyeva T.V.
Klinicheskie sluchai lecheniya gepatotsellyulyarnogo raka v Rossii. Klinicheskiy sluchay 1 Bolee chem 3-letnyaya stabilizatsiya protsessa gepatotsellyulyarnogo raka na fone dlitel'nogo priema preparata sorafenib
Sheko S.S., Dem'yanova G.A.
Place of CDK 4/6 and PARP inhibitors in the modern treatment approach of HER2-negative breast cancer
Editorial B.
Regorafenib: from clinical research to clinical practice
Fedyanin M.Y., Tryakin A.A.
Current algorhytm of screening and early diagnosis of hepatocellular carcinoma
Tikhonov I.N., Pavlov C.S., Mayevskaya M.V., Ivashkin V.T.
Malignant neoplasm of the bronchi and lung: Russian clinical guidelines
Laktionov K.K., Artamonova E.V., Borisova T.N., Breder V.V., Bychkov I.M., Vladimirova L.I., Volkov N.M., Ergnian S.M., Zhabina A.S., Kononets P.V., Kuz’minov A.E., Levchenko E.V., Malikhova O.A., Marinov D.T., Miller S.V., Moiseenko F.V., Mochal’nikova V.V., Novikov S.N., Pikin O.V., Reutova E.V., Rodionov E.O., Sakaeva D.D., Semenova A.I., Smolin A.V., Sotnikov V.M., Tuzikov S.A., Turkin I.N., Tiurin I.E., Chkhikvadze V.D., Kolbanov K.I., Chernichenko A.V., Fedenko A.A., Filonenko E.V., Nevol’skikh A.A., Ivanov S.A., Khailova Z.V., Gevorkian T.G., Butenko A.V., Gil’mutdinova I.R., Gridneva I.V., Eremushkin M.A., Zernova M.A., Kasparov B.S., Kovlen D.V., Kondrat’eva K.O., Konchugova T.V., Korotkova S.B., Krutov A.A., Obukhova O.A., Ponomarenko G.N., Semiglazova T.I., Stepanova A.M., Tkachenko G.A., Khulamkhanova M.M.
Supportive therapy for ovarian cancer
Pokataev I.A., Tyulyandin S.A.
A population-based portrait of breast cancer in russia: a cancer register-based analysis in russian
Poddubnaya I.V., Kolyadina I.V., Kalashnikov N.D., Borisov D.A., Makarova M.V.
Targetnaya terapiya rasprostranennogo raka pochki: problema vybora preparata na primere mul'tikinaznykh ingibitorov
Matveev V.B.
Tsetuksimab pri lechenii metastaticheskogo kolorektal'nogo raka
Sekacheva M.I., Skipenko O.G.
Dual immunological blockade in the treatment of metastatic non-small cell lung cancer: reality and perspectives
Yudin D.I., Laktionov K.K., Laktionova L.V., Breder V.V.
The role of bevacizumab in the treatment of patients with ovarian and cervical cancer
Khokhlova S.V.
Regorafenib in metastatic colorectal cancer: more data for clinical decisions
Petkau V.V., Karimova A.A., Akishina Z.V.
Second primary cancer in patients with head and neck squamous cell carcinoma: case report
Agabekyan G.O., Stelmakh D.K., Aydarbekova A.A.
The role of targeted therapy in the treatment of advanced hepatocellular carcinoma
Shakhnovich E.B., Kerbikov O.B., Kulaga E.A.
Mesto tsetuksimaba v terapii metastaticheskogo raka tolstoy kishki
Artamonova E.V.
Estramustina fosfat (estratsit) v lechenii raka predstatel'noy zhelezy (po materialam Journal of Clinical Oncology, 2005 ASCO Proceedings)
Podregul'skiy K.E.
Quality of life and overall survival are primary priorities of patients with advanced breast cancer: results of sociological research
Kolomejtseva A.A., Bokova S.E.
Cabazitaxel in the treatment of metastatic castration-resistant prostate cancer
Ognerubov N.A.
Squamous cell breast cancer: description of a rare clinical case
Zikiryakhodjaev A.D., Khakimova S.G., Rasskazova E.A., Saribekian E.K., Omarova D.F., Surkova V.S., Khakimova G.G.
PARP inhibitors in female reproductive system cancers
Pokataev I.A., Tyulyandin S.A.
Efficacy and safety of pemetrexed maintenance therapy in advanced non-small-cell lung cancer: a review of phase III studies
Kit O.I., Vladimirova L.Y., Sholokhova E.A.
Denosumab (AMG-162) v profilaktike osteoporoza, vyzvannogo priemom ingibitorov aromatazy u bol'nykh rakom molochnoy zhelezy v ad\"yuvantnoy terapii i u bol'nykh rakom predstatel'noy zhelezy pri polnoy androgennoy blokade
Lichinitser M.R., Semenov N.N.
Neksavar® (sorafenib)v lechenii rasprostranennogo pochechno-kletochnogo raka
Podregul'skiy K.E.
Fraksiparin kak osnovnoe sredstvo profilaktiki tromboembolii legochnoy arterii v posleoperatsionnom periode u bol'nykh kolorektal'nym rakom
Makarov O.G.
Modern ultrasound technologies in monitoring the effectiveness of chemotherapy for cervical cancer
Musaeva Z.R., Chekalova M.A., Mesheryakov A.A.
The potential use of oncolytic viruses in breast cancer: historical aspects and future prospects (literature review)
Morozov D.A., Kolyadina I.V., Poddubnaya I.V., Chumakov P.M., Ilinskaya G.V., Bokhian V.Y., Sopova M.I.
Adenosquamous carcinoma of the colon: case report
Nefedova N.A., Kharlova O.A., Malkov P.G., Kharlov N.S., Danilova N.V.
Osimertinib for the first-line treatment of EGFR-positive non-small cell lung cancer
Reutova E.V., Laktionov K.P., Iudin D.I., Neliubina L.A., Gorokhova G.K., Egorova A.V.
Clinical cases of treatment of hepatocellular carcinoma
Lazarev S.A., Mamontov K.G., Manihas G.M., Antimonik N.Y.
Lechenie metastazov kolorektal'nogo raka v pecheni
Patyutko Y.I., Sagaydak I.V., Pylev A.L., Podluzhnyy A.N., Chuchuev E.S., Shishkina N.A.
Primenenie tsetuksimaba v lechenii ploskokletochnogo raka golovy i shei
Romanov I.S., Kupchan D.Z.
Femara (letrozol) v sovremennoy terapii raka molochnoy zhelezy
Perevodchikova N.I.
8 let nadezhdy: novye dannye issledovaniya ATAS
Primenenie Zomety na fone endokrinnoy terapii Femaroy u bol'nykh rakom molochnoy zhelezy s metastazami v kosti
Konstantinova M.M., Ovchinnikova L.K., Lomakin N.N., Galleev M.G., Neretina E.S., Mukhamedshina G.Z., Mukhametgaleeva F.K.
Immunogistokhimicheskoe opredelenie ekspressii HER2/neu pri rake molochnoy zhelezy (po dannym Smolenskogo oblastnogo onkologicheskogo klinicheskogo dispansera)
Shisterova O.A., Golik E.P.
K voprosu o diagnostike raka yaichnikov pri polineoplaziyakh
Payanidi Y.G., Sel'chuk V.Y., Zhordania K.I., Asanov A.Y., Zakharova T.I., Savelov N.I.
Vozmozhnosti lekarstvennoy terapii raka sheyki matki
Kharitonova T.V.
Aromazin (ekzemestan) v neoad\"yuvantnoy i ad\"yuvantnoy gormonoterapii raka molochnoy zhelezy
Makarenko N.P.
Znachenie taksanov v neoad\"yuvantnoy terapii raka molochnoy zhelezy
Bozhok A.A., Semiglazov V.F., Kletsel' A.E., Arzumanov A.S., Ivanova O.A., Semiglazov V.V.
The modified biopsy technique conducting ultrasound bronchoscopy with endosonographic-guided position of the endoscopic instrument in the area of the pathological focus. The results of the first phase of the clinical trial
Pushkarev E.A., Vazhenin A.V., Kulaev K.I., Iusupov I.M., Zuikov K.S., Popova I.A.
Breast cancer immunophenotype and its relationship with haematopoiesis
Ryabchikov D.A., Chulkova S.V., Shamilov F.A., Chanturia N.V., Zheltikov S.D., Tupitsyn N.N.
Sarcopenia, sarcopenic obesity, myosteatosis as factors of poor prognosis in gastrointestinal tract tumors: review
Dikova T.S., Zatsepina A.Y., Fedorinov D.S., Lyadov V.K.
Don’t let it disappear: new opportunities to prolong the life of HR+ HER2- advanced breast cancer patients. Event review of the satellite symposium. RUSSCO Big Conference «Breast Cancer» (online). January 28th, 2021
Board E.
Modern possibilities of radiological diagnosis of bladder cancer
Suchilova M.M., Nikolaev A.E., Shapiev A.N., Mukhutdinova G.Z., Tkacheva P.V., Nikiforova M.V., Gombolevskiy V.A., Morozov S.P.
Clinical and morphological case of lung cancer with generalized metastases to the internal organs
Vorobeva O.V.
Modern perspectives in sequential therapy for metastatic colorectal cancer with reference to the use of regorafenib
Sekacheva M.I., Nuriev R.I., Rozhkov A.A., Semenkov A.V., Bagmet N.N., Boroda A.M.
Clinical case of long-term use of osimertinib in the treatment of EGFR mutation-positive lung adenocarcinoma
Odintsova S.V., Sviridenko M.A., Cheremnykh A.O., Filippova E.A., Urtenova M.A., Orlov S.V.
Molecular-biological marker Bcl-2 in colorectal cancer: the characteristics, the role of mechanisms regulating apoptosis, the effect on the prognosis (review of literature)
Darenskaia A.D., Dobrova N.V., Stepanova E.V.
Opportunities of the pharmacogenetic approach to personalized tamoxifen breast cancer therapy: case reports
Savelyeva M.I., Dudina I.A., Zaharenkova J.S., Ignatova A.K., Ryzhikova K.A., Sozaeva Z.A., Kudlay D.A., Perfileva O.M., Poddubnaya I.V.
The first experience of immunotherapy application of ipilimumab in combination with chemotherapy of small-cell lung cancer in the Russian population. Analysis of the combined data of two centers, participating in the multicenter randomized phase III study СА 184-156
Kuzminov A.E., Gorbunova V.A., Poddubskaya E.V., Bagrova S.G., Baranova M.P., Laktionov K.K.
Cost-effectiveness analysis of ixabepilone use in monotherapy in patients with locally advanced and metastatic breast cancer resistant to treatment with anthracyclines, taxanes and capecitabin
Kolbin A.S., Mosikyan A.A., Balykina Y.E., Proskurin M.A.
Irreversible electroporation of locally advanced unresectable pancreatic cancer
Patyutko Y.I., Polyakov A.N., Kudashkin N.E., Podluzhnyi D.V., Chistyakova O.V.
Brachytherapy with ultrasound assistance in patients with cervical cancer
Kizhaev Y.E., Razumova E.L., Bessolova O.V.
Long-term treatment of neuroendocrine tumor of the pancreas
Khvastunov R.A., Egorov S.V., Kargin A.V., Kim A.Y.
Bioequivalence assessment of BCD-022 (trastuzumab, manufactured by JSC BIOCAD, Russia) as compared with Herceptin® (F.Hoffmann-La Roche Ltd., Switzerland), used in combination with paclitaxel in HER2-positive metastatic breast cancer patients: findings of the international, double-blind phase III clinical study
Ignatova E.O., Burdaeva O.N., Kopp M.V., Kotiv B.N., Udovitsa D.P., Stroiakovskii D.L., Alekseev S.M., Sheveleva L.P., Khorinko A.V., Shapovalova I.S., Moiseenko V.M., Ivanov R.A.
Clinical and prognostic significance of matrix metalloproteinase-7 and vascular endothelium growth factor in patients with ovarian cancer
Knyazev R.I., Poddubnaya I.V., Bokin I.I., Barinov V.V.
Efficacy and safety of extimia® (empegfilgrastim): results of a double-blind controlled phase iii study in patients with diagnosis «breast cancer» receiving myelosuppressive chemotherapy
Krivorotko P.V., Burdaeva O.N., Nechaeva M.N., Frolova M.A., Kopp M.V., Abrosimova A.A., Ivanov R.A.
Immunological heterogeneity of stage I breast cancer:biological, population-based and prognostic value (international cooperation experience)
Kolyadina I.V., Poddubnaya I.V., Van de Velde C.J., Kuppen P.J., Frank G.A., Komov D.V., Karseladze A.I., Bastiaannet E., Dekker-Ensink N.G.
Targeted therapy for metastatic renal cell carcinoma
Porta C., Tsimafeyev I.V.
Modern technology of radiation therapy: IMRT, VMAT using simultanting integrated boost (SIB) in the complex treatment of squamous cell carcinoma of the anal canal
Tkachev S.I., Glebovskaya V.V., Rasulov A.O., Tsariuk V.F., Aliev V.A., Vodyanik V.V.
Algorithm of treatment of patients with castrate-resistant prostate cancer: modern concept and perspectives
Alekseev B.Y., Nyushko K.M., Kalpinskiy A.S., Kaprin A.D.
New aspects of the first-line chemotherapy in colorectal cancer
Artamonova E.V.
Press-release. The resolution of oncologists of the North-West Federal District: screening for female reproductive system cancers is required
Rezul'taty «Epidemiologicheskoy programmy skrininga HER2-statusa u bol'nykh rakom molochnoy zhelezy» v Rossiyskoy Federatsii
Frank G.A., Poddubnaya I.V., Yagudina R.I., Borisov D.A.
The concept of resectability in the treatment of colorectal cancer liver metastases: the present notion
Bagmet N.N., Bedzhanyan A.L., Polishchuk L.O., Sekacheva M.I., Shatveryan G.A., Skipenko O.G.
Preliminary results of an observational program for estimating the duration of bevacizumab therapy in patients with metastatic colorectal cancer in daily clinical practice
Poddubnaya I.V., Bobrovskaya E.V., Vladimirova L.Y., Gordeev S.S., Davidenko I.S., Emelyanov S.A., Zharkova O.V., Koroleva I.A., Krasilnikova S.Y., Maikoparova S.C., Malysheva T.A., Modestov A.A., Morozov A.N., Stachenko G.B., Strygina E.A., Tlish E.K., Feoktistova P.S., Chichkanova A.S., Sherman N.Z.
Klinicheskiy sluchay effektivnogo lecheniya lapatinibom (Tayverb)i kapetsitabinom (Kseloda) bol'noy disseminirovannym rakom molochnoy zhelezy s giperekspressiey ErbB2 (Her-2/neu) s metastaticheskim porazheniem veshchestva i obolochek golovnogo mozga
Naskhletashvili D.R., Chmutin G.E.
Vozmozhnosti ispol'zovaniya tsetuksimaba dlya lecheniya bol'nykh kolorektal'nym rakom
Orlova R.V., Tyukavina N.V.
Bevatsizumab (Avastin) v kombinatsii s taksanami v 1-y linii lecheniya HER-2-negativnogo metastaticheskogo raka molochnoy zhelezy(Rezul'taty issledovaniya AVADO)
Zhukova L.G.
Predvaritel'nye rezul'taty induktsionnoy khimioterapii s paklitakselom pri mestnorasprostranennom rake sheyki matki
Morkhov K.Y., Kuznetsov V.V., Lebedev A.I., Nechushkina V.M., Zakharova T.I., Tyulyandin S.A.
Targetnaya terapiya raka pochki
Alekseev B.Y., Shegay P.V.
Femara (letrozol) v ad\"yuvantnoy terapii raka molochnoy zhelezy
Stenina M.B.
Vliyanie rekonstruktivno-plasticheskikh operatsiy na kachestvo zhizni bol'nykh rakom molochnoy zhelezy v otdalennom periode
Arslanov K.S., Tkachenko G.A.
1 - 100 of 367 Items 1 2 3 4 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies